Perrigo (PRGO) Cash from Restructuring (2023 - 2026)
Perrigo (PRGO) posted quarterly Cash from Restructuring of $71.4 million for Q1 2026, up 142.86% year-over-year from $29.4 million in Q1 2025, and up 142.86% quarter-over-quarter from $29.4 million in Q1 2025.
Perrigo (PRGO) Cash from Restructuring (2023 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Cash from Restructuring for 4 consecutive years, with $71.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Restructuring rose 142.86% year-over-year to $71.4 million; the TTM figure through Mar 2026 stood at $162.4 million (up 52.63% YoY), while the FY2025 annual figure was $67.0 million, down 32.93% from the prior year.
- Cash from Restructuring grew to $71.4 million in Q1 2026 per PRGO's latest filing, from $29.4 million in the prior quarter.
- Across five years, Cash from Restructuring topped out at $71.4 million in Q1 2026 and bottomed at $4.8 million in Q3 2024.
- Historically, Cash from Restructuring has averaged $32.2 million across 4 years, with a median of $22.4 million in 2023.
- On a YoY basis, Cash from Restructuring climbed as much as 268.83% in 2024 and fell as far as 69.03% in 2024.
- Perrigo's Cash from Restructuring stood at $15.4 million in 2023, then soared by 268.83% to $56.8 million in 2024, then plunged by 48.24% to $29.4 million in 2025, then surged by 142.86% to $71.4 million in 2026.
- Business Quant data shows PRGO's Cash from Restructuring at $71.4 million in Q1 2026, $29.4 million in Q1 2025, and $56.8 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Perrigo | 1.91 Bn | 1.51 Bn | 313.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 13.50 Mn |
| Mar 28, 2026 | 71.40 Mn |
| Mar 29, 2025 | 29.40 Mn |
| Dec 31, 2024 | 56.80 Mn |
| Sep 28, 2024 | 4.80 Mn |
| Dec 31, 2023 | 15.40 Mn |
| Sep 30, 2023 | 15.50 Mn |